http://ec.europa.eu//research/index.cfm?pg=whatsnew en Tue, 18 Jun 2013 08:08:22 GMT http://ec.europa.eu/research/index.cfm?pg=rss For more RSS news feeds click the link above. Tue, 18 Jun 2013 08:08:22 GMT http://ec.europa.eu/research/index.cfm?pg=rss http://ec.europa.eu/rapid/press-release_IP-13-517_en.htm Mon, 10 Jun 2013 00:00:00 GMT press-release_IP-13-517_en.htm http://ec.europa.eu/research/health/infectious-diseases/poverty-diseases/index_en.html Fri, 30 Nov 2012 00:00:00 GMT tag:ch,2012-11-30:/health/infectious-diseases/poverty-diseases/index_en.html http://ec.europa.eu/research/infocentre/theme_en.cfm?item=Special%20Collections&subitem=HIV%20%26%20AIDS See our new special collection of recent articles on HIV and AIDS in the Information Centre. Don't forget you can select the ones you want and convert them into PDFs online. Then download the PDF for later reading or printing.]]> Fri, 30 Nov 2012 00:00:00 GMT tag:ch,2012-11-30:/infocentre/theme_en.cfm?item=Special%20Collections&subitem=HIV%20%26%20AIDS http://ec.europa.eu/research/infocentre/article_en.cfm?id=/research/headlines/news/article_12_11_23_en.html&item=Infocentre&artid=28333 A research project carried out jointly by chemists at Imperial College London in the United Kingdom and biological scientists at the Institut Pasteur/Centre National de la Recherche Scientifique (CNRS) in France have opened the door to a promising new treatment for malaria. The researchers have successfully identified a new means to eradicate blood-borne Plasmodium parasites that cause the disease. Their research was supported in part by a European Research Council (ERC) grant.]]> Fri, 23 Nov 2012 00:00:00 GMT tag:ch,2012-11-23:/infocentre/article_en.cfm?id=/research/headlines/news/article_12_11_23_en.html&item=Infocentre&artid=28333 http://ec.europa.eu/research/infocentre/article_en.cfm?id=/research/headlines/news/article_12_03_01_en.html&item=Infocentre&artid=24074 An international team of researchers has discovered that a protein responsible for protecting some of our body's immune cells from the most common and virulent form of HIV succeeds in its quest because it starves the virus of the molecular building blocks it requires to replicate. The study, published in the journal Nature Immunology, was supported in part by a European Research Council (ERC) grant under the EU's Seventh Framework Programme (FP7). The results could help us understand why some anti-HIV drugs are more effective than others.]]> Thu, 01 Mar 2012 00:00:00 GMT tag:ch,2012-03-01:/infocentre/article_en.cfm?id=/research/headlines/news/article_12_03_01_en.html&item=Infocentre&artid=24074